Showing results (31-40 of 86) with videos related to
Sort By:
Pageof 9
Leukemia Research|July 22, 2016
Early molecular response in chronic myeloid leukemia and halving time: Latest evidencesMassimo Breccia, Matteo Molica, Gioia Colafigli, et al.Blood Cancer Journal|June 26, 2026
Pola-R-CHP as frontline therapy for diffuse large B-cell lymphoma: a systematic review and meta-analysis of randomized trials and real-world evidenceSalvatore Perrone, Matteo Molica, Diana Giannarelli, et al.Annals of Hematology|October 12, 2014
Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatmentMassimo Breccia, Matteo Molica, Irene Zacheo, et al.American Journal of Hematology|August 21, 2019
Maintenance therapy in AML: The past, the present and the futureMatteo Molica, Massimo Breccia, Roberto Foa, et al.Haematologica|December 11, 2025
CPX-351 in secondary/high-risk acute myeloid leukemia: a meta-analysis of randomized and real-world studies encompassing more than 3200 patientsMatteo Molica, Diana Giannarelli, Laura De Fazio, et al.Journal of Clinical Medicine|December 30, 2025
How to Read a Next-Generation Sequencing Report for AML and MDS? What Hematologists Need to KnowSalvatore Perrone, Cristina Tresoldi, Silvia Rigamonti, et al.Cancers|January 11, 2024
Venetoclax: A Game Changer in the Treatment of Younger AML Patients?Matteo Molica, Salvatore Perrone, Vincenzo Federico, et al.Leukemia & Lymphoma|February 17, 2012
Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implicationsStefano Molica, Francesca Romana Mauro, Matteo Molica, et al.Chemotherapy|June 8, 2021
Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and PonatinibMatteo Molica, Carla Mazzone, Iole Cordone, et al.Cancers|December 11, 2025
Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and BeyondMatteo Molica, Claudia Simio, Laura De Fazio, et al.Pageof 9